AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2025
Feb 18, 2025
29821_dirs_2025-02-18_99631529-877d-4ddf-bdfc-d53fe695aa2d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2025-02-13
Reporting Person: Woodworth Emily (SVP, Global Controller and CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | Common Stock | M | 661.0000 | $0.0000 | Acquired | 3867.0000 | Direct |
| 2025-02-14 | Common Stock | F | 315.0000 | $106.1100 | Disposed | 3552.0000 | Direct |
| 2025-02-16 | Common Stock | M | 636.0000 | $0.0000 | Acquired | 4188.0000 | Direct |
| 2025-02-16 | Common Stock | F | 271.0000 | $106.1100 | Disposed | 3917.0000 | Direct |
| 2025-02-17 | Common Stock | M | 667.0000 | $0.0000 | Acquired | 4584.0000 | Direct |
| 2025-02-17 | Common Stock | F | 283.0000 | $106.1100 | Disposed | 4301.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | Restricted Stock Units | $ | A | 5652.0000 | Acquired | 2029-02-13 | Common Stock (5652.0000) | Direct |
| 2025-02-13 | Stock Option (Right to Buy) | $106.1400 | A | 5732.0000 | Acquired | 2035-02-13 | Common Stock (5732.0000) | Direct |
| 2025-02-14 | Restricted Stock Units | $ | M | 661.0000 | Disposed | 2027-02-14 | Common Stock (661.0000) | Direct |
| 2025-02-16 | Restricted Stock Units | $ | M | 636.0000 | Disposed | 2026-02-16 | Common Stock (636.0000) | Direct |
| 2025-02-17 | Restricted Stock Units | $ | M | 667.0000 | Disposed | 2025-02-17 | Common Stock (667.0000) | Direct |
Footnotes
F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F5: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F6: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.